MiMedx Reports, As A Result Of Co.'s Interim Progress Report Submitted Oct. 31, 2018, Nasdaq Has Reconsidered Co.'s Request For Continued Listing And Trading Will Be Suspended As Of Thurs., Nov. 8, 2018
Benzinga Newsdesk